Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: The story does a good job of describing the costs of angiopasty compared to a stress test. The story could have discussed out of pocket costs for patients. The story could have quantified the benefit of stress testing in its ability to avoid angiography and angioplasty associated with it. The story mentions missing cases of heart disease and difficulties of performing the test in older patients as potentional harms of stress testing, but there are other harms that the story should have mentioned. The story adequately describes the design of the current study and points out some important caveats inherent in a database-based study. The story does not exagerrate the seriousness or prevalence of stable heart disease. The story quotes multiple sources. The story mentions angiography as the alternative to stress testing. The story could have done more to describe the pros and cons of angiography compared to stress testing. Clearly stress tests are available. Clearly stress testing is not a new idea. Because the story quotes multiple experts, the reader can assume the story did not rely on a press release as the sole source of information.
Example Output: More stress tests needed before angioplasties, study says

Example Input: The decision by Cleveland County District Judge Thad Balkman in Norman, Oklahoma, came in the first case to go to trial out of 2,700 nationally by states, counties and cities seeking to hold drug companies responsible for the deadly epidemic. Balkman reduced the amount he had awarded in August by $107 million after agreeing with New Brunswick, New Jersey-based J&J that he had made a math error. J&J said it will appeal, and that the award and finding of liability were “neither supported by the facts nor the law.”  A spokesman for Oklahoma Attorney General Mike Hunter said that office is reviewing the decision and will formally respond within the next few days. Opioids were involved in almost 400,000 overdose deaths from 1999 to 2017, according to the U.S. Centers for Disease Control and Prevention. Following a non-jury trial, Balkman ruled in August that Oklahoma had proven that J&J engaged in misleading marketing about the benefits of painkillers, and that their addictive risks caused a public nuisance in the form of the opioid crisis. Hunter had sought to have J&J pay $17 billion to help fund addiction treatment and other services to repair damage from the opioid epidemic over the next 30 years. Balkman, however, awarded only enough money for one year of programs, saying Oklahoma failed to support its claims regarding the need to abate the epidemic in future years. Following the August ruling, Oklahoma asked Balkman for permission to return to his courtroom annually to prove those costs, but Balkman on Friday maintained his prior ruling. J&J, meanwhile, argued that it deserved a $355 million credit, reflecting pre-trial settlements by the drugmakers Purdue Pharma LP and Teva Pharmaceutical Industries Ltd.  Balkman concluded on Friday that state law did not allow such credits. Last month, J&J and four other companies proposed a $48 billion settlement framework to resolve all of the opioid cases they face, with J&J paying $4 billion. Lawyers for the local governments have opposed the proposal. If approved, the settlement would let J&J resolve some of the thousands of product liability lawsuits it faces. The company also faces litigation over whether its baby powder causes cancer, a claim it denies.
Example Output: Oklahoma judge reduces Johnson & Johnson opioid payout to $465 million.

Example Input: While the vaccine didn’t offer much protection the past two years, specialists have fine-tuned the recipe in hopes it will better counter a nasty strain this time around. “Getting vaccinated is going to be the best way to prevent whatever happens,” Dr. Daniel Jernigan, flu chief at the Centers for Disease Control and Prevention, told the Associated Press. Last year’s flu brought double trouble: A new strain started a second wave of illnesses just as the first was winding down, making for one of the longest influenza seasons on record. The year before that marked flu’s highest death toll in recent decades. So far, it doesn’t look like the flu season is getting an early start, Jernigan said. The CDC urges people to get their flu vaccine by the end of October. Typically flu starts widely circulating in November or December, and peaks by February. “Painless,” Health and Human Services Secretary Alex Azar pronounced after getting his own flu shot at a news conference Thursday. If people shrug at the risk, “it’s not just about you,” Azar said. “Vaccinating yourself may also protect people around you,” such as how newborns have some flu protection if their mothers were vaccinated during pregnancy. Scientists are hunting for better flu vaccines, and the Trump administration last week urged a renewed effort to modernize production. Most of today’s vaccine is produced by growing flu virus in chicken eggs, a 70-year-old technology with some flaws. It takes too long to brew new doses if a surprise strain pops up. And intriguingly, newer production techniques just might boost effectiveness. For now, people who get vaccinated and still get sick can expect a milder illness — and a lower risk of pneumonia, hospitalization or death, stressed Dr. William Schaffner of Vanderbilt University and the National Foundation for Infectious Diseases. He’s been known to tell such patients, “I’m always glad to see you’re still here to complain.” Here are some things to know: WHO NEEDS VACCINE? Everybody, starting at 6 months of age, according to the CDC. Flu is most dangerous for people over age 65, young children, pregnant women and people with certain health conditions such as heart disease, asthma or other lung disorders, even diabetes. But it can kill even the young and otherwise healthy. On average, the CDC says flu kills about 24,000 Americans each year. Last year, 135 children died. Parents wouldn’t “drive off with their child not restrained in a car seat, just in case they’re in an accident,” said Dr. Patricia Whitley-Williams, a pediatrician with Rutgers Robert Wood Johnson Medical School. “So why would you not vaccinate your child against the flu?” HOW MANY GET VACCINATED? Not enough, the CDC says. Because flu mutates rapidly, a new vaccine is needed every year. Last year, 45% of adults and 63% of children got vaccinated, according to figures released Thursday. Some groups do a little better. Nearly three-quarters of children under age 5 were vaccinated last year, and just over two-thirds of seniors. HOW BAD WILL THIS YEAR BE? Flu is one of medicine’s most unpredictable foes. For example, last fall started off fairly mild. But in February, a strain notorious for more severe illness, called H3N2, suddenly popped up. Worse, even though each year’s vaccine contains protection against H3N2, the circulating bug had mutated so it wasn’t a good match. A vaccine that had worked well for the first few months of flu season suddenly wasn’t much use. But if that harsh bug returns, this year’s vaccine has been updated to better match it. LOTS OF OPTIONS Manufacturers say up to 169 million vaccine doses will be available this year, and people can ask about different choices. Most will offer protection against four flu strains. Traditional flu shots are for all ages. For needle-phobic adults, one brand uses a needle-free jet injector that pushes vaccine through the skin. And the FluMist nasal spray is for generally healthy people ages 2 through 49, who aren’t pregnant. Two brands are specifically for the 65-plus crowd, whose weakened immune systems don’t respond as well to traditional shots. One is high dose, and the other contains an extra immune-boosting compound. Those brands protect against three flu strains, including the more typically severe ones. And people allergic to eggs have two options, one brand grown in mammal cells instead and another made with genetic technology and insect cells. NO-EGG VACCINES GAINING NEW INTEREST Newer technologies could speed production, which is currently a six-month process. But there’s another reason going egg-free is getting scientists’ attention: Certain strains change a bit while growing in chicken eggs, an adaptation that can make the resulting vaccine a little less protective. It’s mainly a problem for those worrisome H3N2 strains. While it’s not clear how much difference that makes, Schaffner said some doctors already consider using egg-free brands for high-risk patients. OTHER STEPS TO TAKE Cover coughs and sneezes. Wash your hands frequently during flu season. One recent study showed washing is better than hand sanitizers. Ask about anti-flu treatments if you’re at high risk of complications. And most important, stay home if you’re sick to keep from spreading the misery. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
Example Output:
Health officials: It’s time to give flu vaccine another shot.